Zuckerberg's Biohub Partners With DOE, NIH to Invest $1.8 Billion in Biological Data for AI Models

By Kelly Cloonan


A nonprofit co-founded by Mark Zuckerberg is working with the Energy Department, the National Institutes of Health and other funding partners to invest $1.8 billion in building biological data ready for artificial-intelligence models.

Biohub said Wednesday the investment will go toward funding, data, computation, and new measurement technology, with the goal of providing datasets that allow researchers to use AI models to find new ways of preventing and treating diseases.

As part of the investment, the DOE will invest more than $500 million across five years in lab measurement, modeling and computation to build an AI-ready open data resource.

NIH will coordinate the contribution of relevant datasets, repositories and knowledge bases developed through more than $500 million in prior federal investment aligned to the initiative, Biohub said.

The company will work with NIH to standardize the datasets for AI model training. Biohub said the investment may pave the way for a greater understanding of disease and open up new paths for cures.

"An accurate predictive model of biology could dramatically accelerate scientific discovery by enabling scientists to perform experiments digitally," Biohub's head of science Alex Rives said.


Write to Kelly Cloonan at kelly.cloonan@wsj.com


(END) Dow Jones Newswires

October 07, 2026 11:40 ET (15:40 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center